Vagus nerve stimulation (VNS) is generally considered as a palliative treatment for
patients with drug-resistant partial onset epilepsy. We report a case that a patient
with drug-resistant generalized onset epilepsy, Epilepsia Partialis Continua (EPC)
became seizure free for 13 months with VNS combined with antiepileptic medication regimens. A 21-year-old, right-handed
man started having seizures at the age of 18. He reported countless limbs shaking
for about 10 s, and occasional generalized tonic–clonic seizures at a frequency of 5–7 times per
year. He was initially treated with valproic acid (VPA) and carbamazepine (CBZ) with
minimal benefits. Then he was treated with lamotrigine (LTG) 200 mg daily, Levetiracetam (LEV) 1250 mg daily and topiramate (TPM) 200 mg daily with minimal benefits for the last several months. His long-term video-EEG
monitoring revealed small spike wave discharges. Sometimes he couldn't say a word
or have dinner for the twitch of the mouth. A vagus nerve stimulator was subsequently
implanted in Sept 2011. Initial stimulation parameters were: current output 0.25 mA, frequency 30 Hz, pulse width 250 ms, 30 s signal on time, and 5 min signal off time. The patient had two wild twitches of the mouth per week. Then
his stimulation current output was changed to 0.50 mA, and his seizure became countless as pre-operation. Fortunately, he became seizure
free after his stimulation current reverted to 0.25 mA. After one month of seizure freedom, the patient withdrew his LEV and TPM. He has
remained seizure free for almost 9 months, during which time he has been gainfully employed.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of the Neurological SciencesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2013 Published by Elsevier Inc.